MarketBeat cites Hold consensus for Zoetis stock

Published on 10/06/2026 at 04:10 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Revenue hit USD 2.47 billion in second quarter, down 0.20 percent year over year. USD 101.08 target contrasts with the Hold view for Zoetis stock.

ZTS, US98978V1035, Illustration mit AI erstellt.

MarketBeat cited a Hold consensus for Zoetis stock on October 1, 2026, with an average 12-month target of USD 101.08 based on 19 analysts. The rating mix was eight Buys, nine Holds and two Sells, giving investors a quantified picture of caution around the animal-health company.

Guidance reset weighs on growth

StockTitan reported that Zoetis generated USD 2.47 billion of revenue in the second quarter of 2026, down 0.20 percent from the prior-year quarter. Net income was USD 691.00 million, while adjusted diluted earnings per share reached USD 1.87 against a USD 1.85 consensus estimate.

The more consequential figure was the outlook. Zoetis guided to fiscal 2026 revenue of USD 9.12 billion to USD 9.32 billion, compared with earlier guidance of USD 9.68 billion to USD 9.96 billion, while adjusted diluted earnings per share guidance fell to USD 6.15 to USD 6.25 from USD 6.85 to USD 7.00.

Companion animal demand is the pressure point

The second-quarter mix explains why the lower guidance matters. U.S. revenue fell 7.00 percent to USD 1.27 billion, and companion animal sales declined 11.00 percent, according to the same Zoetis filing summary; U.S. livestock sales grew 23.00 percent and international revenue rose 8.00 percent.

The contrast is important for valuation. International growth and livestock demand provided support, but the larger companion-animal franchise faced softer clinic demand, price sensitivity and generic competition. That combination leaves the consensus target dependent on a recovery in the companys core pet-care categories rather than on a single quarter of earnings resilience.

Results date and market reference

Zoetis said on September 24, 2026, that it will review third-quarter 2026 results on November 5, 2026, during an 8:30 a.m. ET webcast. The date gives the market a defined checkpoint for testing whether the lower full-year outlook is stabilizing.

On the NYSE, Zoetis closed at USD 69.62 on October 2, 2026, while its 52-week low was USD 69.52. Lang & Schwarz showed a prior close of EUR 63.10 dated October 2, 2026.